Lion Point Capital

Lion Point Capital as of Sept. 30, 2025

Portfolio Holdings for Lion Point Capital

Lion Point Capital holds 27 positions in its portfolio as reported in the September 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Mineralys Therapeutics (MLYS) 8.4 $1.5M 39k 37.92
Milestone Pharmaceuticals (MIST) 7.5 $1.3M 659k 2.00
Fennec Pharmaceuticals (FENC) 6.5 $1.2M 123k 9.36
Jasper Therapeutics Com New (JSPR) 5.4 $949k 399k 2.38
Avadel Pharmaceuticals Com Shs (AVDL) 5.2 $912k 60k 15.27
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA) 5.2 $909k 23k 38.83
Insmed Com Par $.01 (INSM) 5.1 $900k 6.3k 144.01
Ardelyx (ARDX) 5.1 $897k 163k 5.51
Benitec Biopharma Com New (BNTC) 4.9 $870k 62k 14.03
Syndax Pharmaceuticals (SNDX) 4.8 $846k 55k 15.38
Royalty Pharma Shs Class A (RPRX) 4.3 $755k 21k 35.28
Disc Medicine (IRON) 4.0 $700k 11k 66.08
Bridgebio Pharma (BBIO) 3.9 $691k 13k 51.94
Geron Corporation (GERN) 3.9 $685k 500k 1.37
Arcutis Biotherapeutics (ARQT) 3.8 $665k 35k 18.85
Regenxbio Inc equity us cm (RGNX) 3.2 $557k 58k 9.65
Seres Therapeutics Com New (MCRB) 3.0 $522k 27k 19.24
Moonlake Immunotherapeutics Class A Ord (MLTX) 2.7 $484k 68k 7.17
Kura Oncology (KURA) 2.3 $407k 46k 8.85
Biohaven (BHVN) 1.9 $341k 23k 15.01
Compass Pathways Sponsored Ads (CMPS) 1.9 $332k 58k 5.73
Praxis Precision Medicines I Com New (PRAX) 1.7 $302k 5.7k 53.00
Day One Biopharmaceuticals I (DAWN) 1.7 $296k 42k 7.05
Rocket Pharmaceuticals (RCKT) 1.6 $280k 86k 3.26
Mersana Therapeutics (MRSN) 1.1 $200k 26k 7.76
Humacyte (HUMA) 0.8 $145k 84k 1.74
Spruce Biosciences Com New 0.1 $9.0k 1.0k 8.95